A Functional Assay for Sick Sinus Syndrome Genetic Variants

Background/Aims: Congenital Sick Sinus Syndrome (SSS) is a disorder associated with sudden cardiac death due to severe bradycardia and prolonged pauses. Mutations in HCN4, the gene encoding inward Na + /K + current (I f ), have been described as a cause of congenital SSS. The objective of this study...

Full description

Saved in:
Bibliographic Details
Published in:Cellular physiology and biochemistry Vol. 42; no. 5; pp. 2021 - 2029
Main Authors: Jou, Chuanchau J., Arrington, Cammon B., Barnett, Spencer, Shen, Jiaxiang, Cho, Scott, Sheng, Xiaoming, McCullagh, Patrick C., Bowles, Neil E., Pribble, Chase M., Saarel, Elizabeth V., Pilcher, Thomas A., Etheridge, Susan P., Tristani-Firouzi, Martin
Format: Journal Article
Language:English
Published: Basel, Switzerland S. Karger AG 01-01-2017
Cell Physiol Biochem Press GmbH & Co KG
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background/Aims: Congenital Sick Sinus Syndrome (SSS) is a disorder associated with sudden cardiac death due to severe bradycardia and prolonged pauses. Mutations in HCN4, the gene encoding inward Na + /K + current (I f ), have been described as a cause of congenital SSS. The objective of this study is to develop an SSS model in embryonic zebrafish, and use zebrafish as a moderate-throughput assay to functionally characterize HCN4 variants. Methods: To determine the function of hcn4 in zebrafish, embryos were either bathed in the I f -specific blocker (ZD-7288), or endogenous hcn4 expression was knocked down using splice-blocking morpholinos. To assess whether the zebrafish model discriminates benign from pathogenic variants, we tested four HCN4 mutations known to cause human SSS and four variants of unknown significance (VUS). Results: Pharmacological blockade and knockdown of hcn4 in zebrafish phenocopied human SSS, displaying bradycardia and cardiac pauses in intact embryos and explanted hearts. The zebrafish assay correctly identified all disease-causing variants. Of the VUS, the assay predicted 2 as benign and 2 as hypomorphic variants. Conclusions: We conclude that our embryonic zebrafish assay is a novel and effective tool to functionally characterize human HCN4 variants, which can be translated into important clinical prognostic information.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1015-8987
1421-9778
DOI:10.1159/000479897